Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® C. Difficile specialty page provides c. difficile-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

C. DIFFICILE NEWS - Page 8

A Deeper Look at the Efficacy of Off-Label <em>C. difficile</em> Treatments
A new study takes a look at the efficacy of off-label treatments for Clostridium difficile (C. difficile) infection.
Hospitals Face Medicare Funding Reductions Due to High Infection Rates
Under a program established through the Affordable Care Act, 769 US hospitals will receive Medicare reimbursement reductions due to the high rates of hospital-acquired infections.
Exploring CDC's New Outpatient Antibiotic Stewardship Program
In mid-November, the CDC released the “Core Elements of Outpatient Antibiotic Stewardship.”
Hospital Laundry Facilities Could Spread <i>C. difficile</i>
A study from University of Washington researchers uncovers how hospital laundry facilities may harbor dangerous Clostridium difficile spores, creating a potential community source for the bacterial pathogen.
Social Media Platforms Used for Antibiotic Stewardship Training Program
Researchers at University of Chicago Medicine have created an antibiotic stewardship training program for internal medicine residents that incorporates social media platforms, offering a technological tool for a growing health problem.
Intervention Decreases Inappropriate Urine Testing and Catheter-Associated Urinary Tract Infections
A study using different criteria for urine testing than those outlined by the current Infectious Disease Society of America (IDSA) guidelines, has proven to cut down on the testing of urine samples and inappropriate use of antimicrobials.
“Handshake Stewardship” Program Sees Drop in Antibiotic Use and <em>C. diff</em> Rates
Doctors at the Children’s Hospital Colorado have published their research on a new approach to antibiotic stewardship, with promising reductions in antibiotic use and rates of Clostridium difficile.
FDA Approves Merck's Zinplava to Reduce <i>C. difficile</i> Recurrence in Patients
The US Food and Drug Administration has approved Merck’s Zinplava, a monoclonal antibody that will reduce recurrence of Clostridium difficile in high risk patients.
 
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x